ESC Premium Access

FIDELITY Analysis - Discussant review.

Presentation

About the speaker

Professor Colin Baigent

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
9 presentations
0 follower

5 more presentations in this session

FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes

Speaker: Professor B. Pitt (Ann Arbor, US)

Thumbnail

FIGARO-DKD - Discussant review.

Speaker: Doctor K. Damman (Groningen, NL)

Thumbnail

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes - Part 1

Thumbnail

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes

Speaker: Professor G. Filippatos (Athens, GR)

Thumbnail

FIGARO-DKD / FIDELITY Analysis - Panel discussion.

Thumbnail

Access the full session

Hot Line - FIGARO-DKD / FIDELITY Analysis

Speakers: Professor C. Baigent, Professor B. Pitt, Doctor K. Damman, Professor G. Filippatos
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

27 August 2021

Open Access

GUIDE-HF: haemodynamic-guided management of heart failure – randomised arm primary outcomes

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by

logo Novo Nordisk